An Emerging Global Leader in the New Generation of Anti-Infective Therapies. Recce Pharmaceuticals Ltd (ASX:RCE) is an Australian based globally-focussed, biotechnology company engaged in the development and commercialisation of a new class of synthetic anti-infectives.
View the full Corporate Spotlight
 (20min delay)
|
|||||
|
Last
41.0¢ |
Change
0.035(9.33%) |
Mkt cap ! $118.5M | |||
| Open | High | Low | Value | Volume |
| 38.0¢ | 41.5¢ | 38.0¢ | $49.36K | 121.4K |
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 2192 | 41.0¢ |
| Price($) | Vol. | No. |
|---|---|---|
| 41.5¢ | 33302 | 3 |
| Last trade - 14.33pm 11/08/2025 (20 minute delay) ? |
|
|||||
|
Last
41.0¢ |
Change
0.035 ( 7.89 %) |
||||
| Open | High | Low | Volume | ||
| 39.0¢ | 41.0¢ | 39.0¢ | 23622 | ||
| Last updated 14.36pm 11/08/2025 ? | |||||
| RCE (ASX) Chart |
